PRESS RELEASE published on 05/16/2025 at 17:45, 1 year 2 months ago Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital Median Technologies discloses total voting rights and shares as of April 30, 2025, in compliance with regulations. The French company utilizes AI for cancer diagnosis and treatment Voting Rights Shares AI Median Technologies Cancer Diagnosis
PRESS RELEASE published on 05/16/2025 at 17:45, 1 year 2 months ago Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital de Median Technologies au 30 avril 2025, société spécialisée en logiciels dispositifs médicaux et imagerie médicale Déclaration Droits De Vote Actions Median Technologies Logiciels Médicaux
BRIEF published on 03/14/2025 at 17:50, 1 year 4 months ago Median Technologies Maintient son Éligibilité au Dispositif PEA-PME PEA-PME Euronext Growth Éligibilité Avantages Fiscaux Median Technologies
BRIEF published on 03/14/2025 at 17:50, 1 year 4 months ago Median Technologies Maintains its Eligibility for the PEA-PME Scheme PEA-PME Euronext Growth Tax Benefits Eligibility Median Technologies
PRESS RELEASE published on 03/14/2025 at 17:45, 1 year 4 months ago Etat membre d'origine / Choix de l’autorité compétente pour le contrôle de l’information réglementée Median Technologies confirms eligibility for the PEA-PME scheme, meeting criteria of <5,000 employees and annual turnover <1.5 billion euros. Shares remain in PEA-PME accounts with tax benefits Eligibility Criteria Tax Advantages Median Technologies PEA-PME Scheme Stock Savings Plan
BRIEF published on 02/24/2025 at 17:50, 1 year 5 months ago Median Technologies : Présentation d'eyonis™ LCS à l'ECR 2025 Intelligence Artificielle Median Technologies Cancer Du Poumon Eyonis™ LCS ECR 2025
BRIEF published on 02/24/2025 at 17:50, 1 year 5 months ago Median Technologies: Presentation of eyonis™ LCS at ECR 2025 Artificial Intelligence Median Technologies Lung Cancer Eyonis™ LCS ECR 2025
PRESS RELEASE published on 02/24/2025 at 17:45, 1 year 5 months ago Informations privilégiées / Autres communiqués Median Technologies présentera eyonis™ LCS, logiciel IA pour dépistage cancer poumon, à l’ECR. Validation clinique réussie. Dossiers réglementaires soumis bientôt IA Dépistage Median Technologies Cancer Du Poumon Eyonis LCS
BRIEF published on 01/31/2025 at 08:05, 1 year 6 months ago Median Technologies dévoile ses résultats financiers 2024 et ses perspectives 2025 Résultats Financiers Median Technologies Eyonis™ LCS FDA Approbation Expansion 2025
BRIEF published on 01/31/2025 at 08:05, 1 year 6 months ago Median Technologies unveils its 2024 financial results and its 2025 outlook Financial Results FDA Approval Median Technologies Eyonis™ LCS Expansion 2025
Published on 08/07/2026 at 23:15, 16 hours 42 minutes ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 16 hours 57 minutes ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 17 hours 27 minutes ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 17 hours 42 minutes ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/07/2026 at 23:21, 16 hours 35 minutes ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 20 hours 26 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 20 hours 41 minutes ago ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 21 hours 46 minutes ago Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:00, 21 hours 56 minutes ago E-PANGO: Composition du capital au 31 juillet 2026
Published on 08/07/2026 at 18:54, 21 hours 3 minutes ago Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 21 hours 3 minutes ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 21 hours 16 minutes ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 21 hours 16 minutes ago Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 21 hours 57 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026